IL-27 limits central nervous system viral clearance by promoting IL-10 and enhances demyelination

Journal of Immunology

Volumn 193, Issue 1, 2014, Pages 285-294

  De Aquino, Maria Teresa P ^a   Kapil, Parul ^a   Hinton, David R ^b   Phares, Timothy W ^a   Puntambekar, Shweta S ^a   Savarin, Carine ^a   Bergmann, Cornelia C ^a   Stohlman, Stephen A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 27; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CELL POPULATION; CELLULAR SECRETION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DEMYELINATION; DISEASE SEVERITY; ENCEPHALOMYELITIS; FEMALE; HEPATITIS; IMMUNE RESPONSE; MALE; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; TISSUE INJURY; VIRAL CLEARANCE; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ANIMALS; CENTRAL NERVOUS SYSTEM; CORONAVIRUS INFECTIONS; DEMYELINATING DISEASES; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; INTERLEUKIN-10; INTERLEUKINS; MICE; MICE, KNOCKOUT; MURINE HEPATITIS VIRUS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 84903648169     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400058     Document Type: Article

References (58)

1. Kastelein, R. A., C. A. Hunter, and D. J. Cua. 2007. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu. Rev. Immunol. 25: 221-242.
2. Hall, A. O., J. S. Silver, and C. A. Hunter. 2012. The immunobiology of IL-27. Adv. Immunol. 115: 1-44.
3. Takeda, A., S. Hamano, A. Yamanaka, T. Hanada, T. Ishibashi, T. W. Mak, A. Yoshimura, and H. Yoshida. 2003. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J. Immunol. 170: 4886-4890.
4. Villarino, A. V., E. Huang, and C. A. Hunter. 2004. Understanding the pro-and anti-inflammatory properties of IL-27. J. Immunol. 173: 715-720.
5. Villarino, A., L. Hibbert, L. Lieberman, E. Wilson, T. Mak, H. Yoshida, R. A. Kastelein, C. Saris, and C. A. Hunter. 2003. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19: 645-655.
6. Findlay, E. G., R. Greig, J. S. Stumhofer, J. C. Hafalla, J. B. de Souza, C. J. Saris, C. A. Hunter, E. M. Riley, and K. N. Couper. 2010. Essential role for IL-27 receptor signaling in prevention of Th1-mediated immunopathology during malaria infection. J. Immunol. 185: 2482-2492.
7. Kelchtermans, H., A. Billiau, and P. Matthys. 2008. How interferon-g keeps autoimmune diseases in check. Trends Immunol. 29: 479-486.
8. Scheller, J., A. Chalaris, D. Schmidt-Arras, and S. Rose-John. 2011. The proand anti-inflammatory properties of the cytokine interleukin-6. Biochim. Biophys. Acta 1813: 878-888.
9. Villarino, A. V., J. S. Stumhofer, C. J. Saris, R. A. Kastelein, F. J. de Sauvage, and C. A. Hunter. 2006. IL-27 limits IL-2 production during Th1 differentiation. J. Immunol. 176: 237-247.
10. Hall, A. O., D. P. Beiting, C. Tato, B. John, G. Oldenhove, C. G. Lombana, G. H. Pritchard, J. S. Silver, N. Bouladoux, J. S. Stumhofer, et al. 2012. The cytokines interleukin 27 and interferon-g promote distinct Treg cell populations required to limit infection-induced pathology. Immunity 37: 511-523.
11. Villegas-Mendez, A., E. Gwyer Findlay, J. B. de Souza, L. M. Grady, C. J. Saris, T. E. Lane, E. M. Riley, and K. N. Couper. 2013. WSX-1 signalling inhibits CD4+ T cell migration to the liver during malaria infection by repressing chemokine-independent pathways. PLoS ONE 8: e78486.
12. Cox, J. H., N. M. Kljavin, N. Ramamoorthi, L. Diehl, M. Batten, and N. Ghilardi. 2011. IL-27 promotes T cell-dependent colitis through multiple mechanisms. J. Exp. Med. 208: 115-123.
13. Wojno, E. D., N. Hosken, J. S. Stumhofer, A. C. O'Hara, E. Mauldin, Q. Fang, L. A. Turka, S. D. Levin, and C. A. Hunter. 2011. A role for IL-27 in limiting T regulatory cell populations. J. Immunol. 187: 266-273.
14. Villarino, A. V., J. Larkin, III, C. J. Saris, A. J. Caton, S. Lucas, T. Wong, F. J. de Sauvage, and C. A. Hunter. 2005. Positive and negative regulation of the IL-27 receptor during lymphoid cell activation. J. Immunol. 174: 7684-7691.
15. Ouaked, N., P. Y. Mantel, C. Bassin, S. Burgler, K. Siegmund, C. A. Akdis, and C. B. Schmidt-Weber. 2009. Regulation of the Foxp3 gene by the Th1 cytokines: the role of IL-27-induced STAT1. J. Immunol. 182: 1041-1049.
16. Hölscher, C., A. Hölscher, D. Rückerl, T. Yoshimoto, H. Yoshida, T. Mak, C. Saris, and S. Ehlers. 2005. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J. Immunol. 174: 3534-3544.
17. Imamichi, T., J. Yang, D. W. Huang, T. W. Brann, B. A. Fullmer, J. W. Adelsberger, R. A. Lempicki, M. W. Baseler, and H. C. Lane. 2008. IL-27, a novel anti-HIV cytokine, activates multiple interferon-inducible genes in macrophages. AIDS 22: 39-45.
18. Greenwell-Wild, T., N. Vázquez, W. Jin, Z. Rangel, P. J. Munson, and S. M. Wahl. 2009. Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon. Blood 114: 1864-1874.
19. Frank, A. C., X. Zhang, A. Katsounas, J. P. Bharucha, S. Kottilil, and T. Imamichi. 2010. Interleukin-27, an anti-HIV-1 cytokine, inhibits replication of hepatitis C virus. J. Interferon Cytokine Res. 30: 427-431.
20. Mayer, K. D., K. Mohrs, W. Reiley, S. Wittmer, J. E. Kohlmeier, J. E. Pearl, A. M. Cooper, L. L. Johnson, D. L. Woodland, and M. Mohrs. 2008. Cutting edge: T-bet and IL-27R are critical for in vivo IFN-γ production by CD8 T cells during infection. J. Immunol. 180: 693-697.
21. Sun, J., H. Dodd, E. K. Moser, R. Sharma, and T. J. Braciale. 2011. CD4+ T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs. Nat. Immunol. 12: 327-334.
22. Perona-Wright, G., J. E. Kohlmeier, E. Bassity, T. C. Freitas, K. Mohrs, T. Cookenham, H. Situ, E. J. Pearce, D. L. Woodland, and M. Mohrs. 2012. Persistent loss of IL-27 responsiveness in CD8+ memory T cells abrogates IL-10 expression in a recall response. Proc. Natl. Acad. Sci. USA 109: 18535-18540.
23. Trandem, K., J. Zhao, E. Fleming, and S. Perlman. 2011. Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis. J. Immunol. 186: 3642-3652.
24. Sun, J., R. Madan, C. L. Karp, and T. J. Braciale. 2009. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat. Med. 15: 277-284.
25. Nelson, D. A., M. D. Tolbert, M. G. Clemens, and K. L. Bost. 2010. Interleukin-27 expression following infection with the murine gammaherpesvirus 68. Cytokine 51: 184-194.
26. Harker, J. A., A. Dolgoter, and E. I. Zuniga. 2013. Cell-intrinsic IL-27 and gp130 cytokine receptor signaling regulates virus-specific CD4+ T cell responses and viral control during chronic infection. Immunity 39: 548-559.
27. Batten, M., J. Li, S. Yi, N. M. Kljavin, D. M. Danilenko, S. Lucas, J. Lee, F. J. de Sauvage, and N. Ghilardi. 2006. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7: 929-936.
28. Stumhofer, J. S., A. Laurence, E. H. Wilson, E. Huang, C. M. Tato, L. M. Johnson, A. V. Villarino, Q. Huang, A. Yoshimura, D. Sehy, et al. 2006. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7: 937-945.
29. Fitzgerald, D. C., G. X. Zhang, M. El-Behi, Z. Fonseca-Kelly, H. Li, S. Yu, C. J. Saris, B. Gran, B. Ciric, and A. Rostami. 2007. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 8: 1372-1379.
30. Bergmann, C. C., T. E. Lane, and S. A. Stohlman. 2006. Coronavirus infection of the central nervous system: host-virus stand-off. Nat. Rev. Microbiol. 4: 121-132.
31. Bender, S. J., and S. R. Weiss. 2010. Pathogenesis of murine coronavirus in the central nervous system. J. Neuroimmune Pharmacol. 5: 336-354.
32. Phares, T. W., S. A. Stohlman, and C. C. Bergmann. 2013. Intrathecal humoral immunity to encephalitic RNA viruses. Viruses 5: 732-752.
33. Couper, K. N., D. G. Blount, and E. M. Riley. 2008. IL-10: the master regulator of immunity to infection. J. Immunol. 180: 5771-5777.
34. Puntambekar, S. S., C. C. Bergmann, C. Savarin, C. L. Karp, T. W. Phares, G. I. Parra, D. R. Hinton, and S. A. Stohlman. 2011. Shifting hierarchies of interleukin-10-producing T cell populations in the central nervous system during acute and persistent viral encephalomyelitis. J. Virol. 85: 6702-6713.
35. Anghelina, D., J. Zhao, K. Trandem, and S. Perlman. 2009. Role of regulatory T cells in coronavirus-induced acute encephalitis. Virology 385: 358-367.
36. de Aquino, M. T., S. S. Puntambekar, C. Savarin, C. C. Bergmann, T. W. Phares, D. R. Hinton, and S. A. Stohlman. 2013. Role of CD25+CD4+ T cells in acute and persistent coronavirus infection of the central nervous system. Virology 447: 112-120.
37. Tirotta, E., P. Duncker, J. Oak, S. Klaus, M. R. Tsukamoto, L. Gov, and T. E. Lane. 2013. Epstein-Barr virus-induced gene 3 negatively regulates neuroinflammation and T cell activation following coronavirus-induced encephalomyelitis. J. Neuroimmunol. 254: 110-116.
38. Kapil, P., R. Atkinson, C. Ramakrishna, D. J. Cua, C. C. Bergmann, and S. A. Stohlman. 2009. Interleukin-12 (IL-12), but not IL-23, deficiency ameliorates viral encephalitis without affecting viral control. J. Virol. 83: 5978-5986.
39. Fleming, J. O., M. D. Trousdale, F. A. el-Zaatari, S. A. Stohlman, and L. P. Weiner. 1986. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J. Virol. 58: 869-875.
40. Ireland, D. D., S. A. Stohlman, D. R. Hinton, P. Kapil, R. H. Silverman, R. A. Atkinson, and C. C. Bergmann. 2009. RNase L mediated protection from virus induced demyelination. PLoS Pathog. 5: e1000602.
41. Esposito, M., F. Ruffini, A. Bergami, L. Garzetti, G. Borsellino, L. Battistini, G. Martino, and R. Furlan. 2010. IL-17-and IFN-γ-secreting Foxp3+ T cells infiltrate the target tissue in experimental autoimmunity. J. Immunol. 185: 7467-7473.
42. Kapil, P., N. B. Butchi, S. A. Stohlman, and C. C. Bergmann. 2012. Oligodendroglia are limited in type I interferon induction and responsiveness in vivo. Glia 60: 1555-1566.
43. Molle, C., M. Nguyen, V. Flamand, J. Renneson, F. Trottein, D. De Wit, F. Willems, M. Goldman, and S. Goriely. 2007. IL-27 synthesis induced by TLR ligation critically depends on IFN regulatory factor 3. J. Immunol. 178: 7607-7615.
44. Pirhonen, J., J. Sirén, I. Julkunen, and S. Matikainen. 2007. IFN-a regulates Tolllike receptor-mediated IL-27 gene expression in human macrophages. J. Leukoc. Biol. 82: 1185-1192.
45. Phares, T. W., S. A. Stohlman, M. Hwang, B. Min, D. R. Hinton, and C. C. Bergmann. 2012. CD4 T cells promote CD8 T cell immunity at the priming and effector site during viral encephalitis. J. Virol. 86: 2416-2427.
46. Castro, R. F., and S. Perlman. 1995. CD8+ T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity. J. Virol. 69: 8127-8131.
47. Bergmann, C. C., Q. Yao, M. Lin, and S. A. Stohlman. 1996. The JHM strain of mouse hepatitis virus induces a spike protein-specific Db-restricted cytotoxic T cell response. J. Gen. Virol. 77: 315-325.
48. Fujio, K., T. Okamura, and K. Yamamoto. 2010. The family of IL-10-secreting CD4+ T cells. Adv. Immunol. 105: 99-130.
49. Pot, C., L. Apetoh, and V. K. Kuchroo. 2011. Type 1 regulatory T cells (Tr1) in autoimmunity. Semin. Immunol. 23: 202-208.
50. Marten, N. W., S. A. Stohlman, J. Zhou, and C. C. Bergmann. 2003. Kinetics of virus-specific CD8+-T-cell expansion and trafficking following central nervous system infection. J. Virol. 77: 2775-2778.
51. Batten, M., N. Ramamoorthi, N. M. Kljavin, C. S. Ma, J. H. Cox, H. S. Dengler, D. M. Danilenko, P. Caplazi, M.Wong, D. A. Fulcher, et al. 2010. IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells. J. Exp. Med. 207: 2895-2906.
52. Wojno, E. D., and C. A. Hunter. 2012. New directions in the basic and translational biology of interleukin-27. Trends Immunol. 33: 91-97.
53. Collison, L. W., V. Chaturvedi, A. L. Henderson, P. R. Giacomin, C. Guy, J. Bankoti, D. Finkelstein, K. Forbes, C. J. Workman, S. A. Brown, et al. 2010. IL-35-mediated induction of a potent regulatory T cell population. Nat. Immunol. 11: 1093-1101.
54. Kochetkova, I., S. Golden, K. Holderness, G. Callis, and D. W. Pascual. 2010. IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10. J. Immunol. 184: 7144-7153.
55. Huang, C. H., E. X. Loo, I. C. Kuo, G. H. Soh, D. L. Goh, B. W. Lee, and K. Y. Chua. 2011. Airway inflammation and IgE production induced by dust mite allergen-specific memory/effector Th2 cell line can be effectively attenuated by IL-35. J. Immunol. 187: 462-471.
56. Liu, F., F. Tong, Y. He, and H. Liu. 2011. Detectable expression of IL-35 in CD4+ T cells from peripheral blood of chronic hepatitis B patients. Clin. Immunol. 139: 1-5.
57. Zandian, M., K. R. Mott, S. J. Allen, O. Dumitrascu, J. Z. Kuo, and H. Ghiasi. 2011. Use of cytokine immunotherapy to block CNS demyelination induced by a recombinant HSV-1 expressing IL-2. Gene Ther. 18: 734-742.
58. Richards, M. H., M. T. Getts, J. R. Podojil, Y. H. Jin, B. S. Kim, and S. D. Miller. 2011. Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS. J. Autoimmun. 36: 142-154.